Viewing Study NCT00648167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-02-21 @ 10:19 AM
Study NCT ID: NCT00648167
Status: COMPLETED
Last Update Posted: 2017-04-04
First Post: 2008-03-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
Sponsor: Keryx Biopharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hyperphosphatemia View
None End-stage Renal Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ESRD View
None end-stage renal disease View
None end stage renal disease View
None hemodialysis View
None dialysis View
None kidney failure View
None renal failure View
None kidney View
None renal View
None phosphate binder View
None phosphorus View